Literature DB >> 8554331

beta-Cryptoxanthin selectively increases in human chylomicrons upon ingestion of tangerine concentrate rich in beta-cryptoxanthin esters.

T Wingerath1, W Stahl, H Sies.   

Abstract

beta-Cryptoxanthin is a major source of vitamin A, often second only to beta-carotene, and is present in fruits such as oranges, tangerines, and papayas. Here, we studied the uptake of this carotenoid upon ingestion of tangerine juice concentrate, rich in beta-cryptoxanthin esters. Increasing amounts of free beta-cryptoxanthin were detected in chylomicrons and serum. Peak levels in chylomicrons were reached at t = 6 h, and the concentration returned toward basal levels at t = 9 h. No beta-cryptoxanthin esters were detected in chylomicrons or serum, indicating efficient cleavage in the intestine before the carotenoid is incorporated into lipoproteins by the liver. Other xanthophyll esters, e.g., of zeaxanthin and lutein, were present in low amounts in the tangerine concentrate. As with beta-cryptoxanthin, no esters appeared in serum or chylomicrons, suggesting that the cleavage of carotenoid esters prior to release into the lymphatic circulation occurs generally in human oxocarotenoid biokinetics.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8554331     DOI: 10.1006/abbi.1995.0052

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

Review 1.  Absorption, metabolism, and functions of β-cryptoxanthin.

Authors:  Betty J Burri; Michael R La Frano; Chenghao Zhu
Journal:  Nutr Rev       Date:  2016-01-07       Impact factor: 7.110

2.  Retinol metabolism in the mollusk Osilinus lineatus indicates an ancient origin for retinyl ester storage capacity.

Authors:  Manuel Gesto; L Filipe C Castro; Maria Armanda Reis-Henriques; Miguel Machado Santos
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

3.  Overall skin tone and skin-lightening-improving effects with oral supplementation of lutein and zeaxanthin isomers: a double-blind, placebo-controlled clinical trial.

Authors:  Vijaya Juturu; James P Bowman; Jayant Deshpande
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-10-07

Review 4.  Fucoxanthin: A Promising Phytochemical on Diverse Pharmacological Targets.

Authors:  Mumtaza Mumu; Ayan Das; Talha Bin Emran; Saikat Mitra; Fahadul Islam; Arpita Roy; Md Mobarak Karim; Rajib Das; Moon Nyeo Park; Deepak Chandran; Rohit Sharma; Mayeen Uddin Khandaker; Abubakr M Idris; Bonglee Kim
Journal:  Front Pharmacol       Date:  2022-08-02       Impact factor: 5.988

5.  Astaxanthin prevents changes in the activities of thioredoxin reductase and paraoxonase in hypercholesterolemic rabbits.

Authors:  Paula R Augusti; Andréia Quatrin; Sabrina Somacal; Greicy Mm Conterato; Rocheli Sobieski; Amanda R Ruviaro; Luana H Maurer; Marta Mf Duarte; Miguel Roehrs; Tatiana Emanuelli
Journal:  J Clin Biochem Nutr       Date:  2012-06-08       Impact factor: 3.114

Review 6.  Why is Zeaxanthin the Most Concentrated Xanthophyll in the Central Fovea?

Authors:  Justyna Widomska; John Paul SanGiovanni; Witold K Subczynski
Journal:  Nutrients       Date:  2020-05-07       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.